Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Futa Mimoto
Introduction
Futa Mimoto, a prominent inventor based in Shizuoka, Japan, has made significant contributions to the field of biochemistry and biotechnology. With a total of 13 patents to his name, Mimoto's work focuses on enhancing the functionality and stability of polypeptides, particularly in the context of antibody engineering.
Latest Patents
Among his latest innovations, Mimoto has developed a heterodimerized polypeptide that features an Fc region constructed from two polypeptides with distinct amino acid sequences. This innovative approach has led to the creation of a heterodimerized polypeptide that exhibits enhanced functionality compared to traditional homodimers. Furthermore, he has improved the stability of polypeptides by modifying the amino acids in the loop region of the antibody's Fc region. His modifications successfully yield polypeptides with maintained or enhanced FcγR-binding activity while also ensuring improved thermal stability and minimized aggregate content, showcasing Mimoto's commitment to advancing scientific understanding in his field.
Career Highlights
Futa Mimoto works at Chugai Seiyaku Kabushiki Kaisha, a company that plays a crucial role in the pharmaceutical sector. His career is marked by a dedication to research and innovation, contributing to advancements that have the potential to impact various therapeutic applications.
Collaborations
Mimoto collaborates with other esteemed professionals in the industry, including coworkers Tomoyuki Igawa and Taichi Kuramochi. These partnerships facilitate a collaborative atmosphere that fosters creativity and drives the success of their collective research endeavors.
Conclusion
Futa Mimoto's dedication to innovation and his substantial contributions to the realm of polypeptide science are evident in his extensive patent portfolio. As the field continues to evolve, Mimoto's work promises to pave the way for new therapeutic strategies, solidifying his status as a key inventor in biotechnology.